CYGX already received a grant by the NIH quite a while back as I recall. It was for about $100,000 on mice studies if memory serves well.
The FDA doesn't care about a company's past history as far as grants received so on and so forth. All the FDA wants to see
is hard cold data, how that data was obtained, the accuracy
(GMPs, GLPs, SOPs) of the data aquired, logbooks, laboratory notebooks, when the data was written in, what was used, how it was used, why, etc, etc.
They don't base their total finding on this, but if something was said to be done by someone on such and such a date on such and such an instrument and nothing was logged into the logbook as such or it was not entered into the notebook as such..... it did NOT happen. They can be very tough sticklers.
Sometimes they will not leave an audit until something is found and they will look and look and look until they do.
Then it is a warning letter or possible 483.
They are thorough, but reputations, grants, praises.....
mean nothing. Only the how, what, why, and documentation
are important.